Product Images Lacosamide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Lacosamide NDC 68083-480 by Gland Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Lacosamide-Structure - Lacosamide Structure

Lacosamide-Structure - Lacosamide Structure

lacosamide-carton-label - lacosamide carton label

lacosamide-carton-label - lacosamide carton label

This is a medication guide for Lacosamide Injection. Each single-dose vial contains a solution for infusion of 200 mg/20 mL of the active ingredient, lacosamide. The medication is only for intravenous use and the usual dosage should be determined by a physician. The solution also contains inactive ingredients including sodium chloride, hydrochloric acid, and water for injection. The medication should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) and should be kept out of reach of children. The medication is manufactured by Gland Pharma Limited in Hyderabad, India.*

lacosamide-container-label - lacosamide container label

lacosamide-container-label - lacosamide container label

Lacosamide Injection, USP manufactured by Gland Pharma Limited in Hyderabad, India with an ANDS ML No of 2/MD/TS/2016/F/6 and PSLAB-XXXXXX-XX. The injection contains 200mg/20mL of 10mg/mL Lacosamide for IV use only. It is essential to read package insert for dosages and discard unused portions. The injection should be kept at a controlled room temperature and away from children. It is a single-dose vial that has an NDC of 68083-480-10 for Rx only.*

Lacosamide-Figure-1 - lacosamide figure 1

Lacosamide-Figure-1 - lacosamide figure 1

Lacosamide-Figure-2 - lacosamide figure 2

Lacosamide-Figure-2 - lacosamide figure 2

This appears to be a figure or graph showing the Responder Rate for Lacosamide and Placebo groups in Studies 2, 3, and 4. The figure shows the proportion of patients who responded to treatment, with Lacosamide and Placebo being compared. Unfortunately, without the actual graph it is difficult to provide more detail.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.